secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTIVION, INC. (AORT)
CIK:        0000784199
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0000784199-22-000184
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artivion Q3 revenue $76.8M (+6% GAAP, +11% constant currency); net loss $0.34/share
--------------------------------------------------------------------------------

- Revenue $76.8M, up 6% GAAP and 11% constant currency vs Q3 2021.
- On-X revenues up 17% GAAP and 19% constant currency; tissue processing up 13% constant currency.
- Net loss ($13.7M) or ($0.34)/share vs net income $10.6M ($0.26) in Q3 2021. Includes $4.7M PROACT Xa termination charge and $3.7M FX loss.
- Non-GAAP net loss ($1.9M) or ($0.05)/share vs ($1.2M) ($0.03) prior year.
- 2022 outlook: narrowing constant currency revenue growth to 9-10%; full-year revenue expected $313M-$316M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/784199/000078419922000184/0000784199-22-000184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/784199/000078419922000184/aort-20221103.htm
  HTML page:      https://secwatch.observer/filing/0000784199-22-000184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer